YVONNE HALL: Open Payments
NPI 1922029164 · RIO RANCHO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 41 payments from 8 companies in 2025. Trend: 2023 $925 · 2024 $1,207 · 2025 $1,185
Food & beverage: $1,185
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $383 |
| E.R. Squibb & Sons, L.L.C. | 5 | $176 |
| Neurocrine BioSciences, Inc. | 7 | $166 |
| Janssen Pharmaceuticals, Inc | 3 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $163 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| ABBVIE INC. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: UZEDY, COBENFY, INGREZZA, CAPLYTA, INVEGA SUSTENNA, AUSTEDO XR, Auvelity, VRAYLAR.
Industry payments across NM — which companies pay providers there.
